Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study

Lancet

Volumn 354, Issue 9180, 1999, Pages 708-715

  Ragmin, F ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; DALTEPARIN; PLACEBO;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION;

EID: 0033612951     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)07349-3     Document Type: Article

References (24)

1. Luchi R., Scott S., Deupree R. Comparison of medical and surgical treatment for unstable angina pectoris. N Engl J Med. 316:1987;977-984.
2. Anderson H.V., Cannon C.P., Stone P.H.et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial: a randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol. 26:1995;1643-1650.
3. Boden W.E., O'Rourke R.A., Crawford M.H.et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs non-Q-wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators. N Engl J Med. 338:1998;1785-1792.
4. McCulluogh P.A., O'Neill W., Graham M.et al. A prospective randomised trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy. J Am Coll Cardiol. 32:1998;596-605.
5. De Feyter P.J., Serruys P.W., van den Brand M.et al. Emergency coronary angioplasty in refractory unstable angina. N Engl J Med. 313:1985;342-346.
6. Unstable angina: diagnosis and management. Clinical practice guidelines. US Department of Health and Human Services. AHCPR Publication No 94-0602, 1994.
7. Low-molecular-weight heparin during instability in coronary artery disease. Lancet. 347:1996;561-568.
8. Cohen M., Demers C., Gurfinkel E.P.et al. A comparison of low molecular-weight heparin with unfractionated heparin for unstable coronary artery disease: Efficacy and Safety of Subcutaneous Enoxaparin in non-Q-wave Coronary Events Study Group. N Engl J Med. 337:1998;447-452.
9. Campbell R.W., Wallentin L., Verheugt F.W.et al. Management strategies for a better outcome in unstable coronary artery disease. Clin Cardiol. 21:1998;314-322.
10. Theroux P., Fuster V. Acute coronary syndromes unstable angina and non-Q-wave myocardial infarction. Circulation. 97:1998;1195-1206.
11. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high risk coronary angioplasty. N Engl J Med. 330:1994;956-961.
12. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: the CAPTURE study. Lancet. 349:1997;1429-1435.
13. Serruys P.W., de Jaegere P., Kiemeneij F.et al. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
14. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet. 352:1998;87-92.
15. Favaloro R.G. Landmarks in the development of coronary artery bypass surgery. Circulation. 98:1998;466-478.
16. Nyman I., Areskog M., Areskog N.H., Swahn E., Wallentin L. Very early risk stratification by electrocardiogram at rest in men with suspected unstable coronary heart disease: The RISC Study Group. J Intern Med. 234:1993;293-301.
17. Prevention of coronary heart disease in clinical practice: recommendation. Eur Heart J. 19:1998;1434-1503.
18. Abdelmeguid A.E., Topol E.J. The myth of the myocardial infarctlet during percutaneous coronary revascularisation procedures. Circulation. 94:1996;3369-3375.
19. Prolonged low molecular mass heparin (dalteparin) in unstable coronary artery disease: a prospective randomised multicenter study - the FRISC II medial trial. Lancet. 354:1999;701-706.
20. Coronary angioplasty versus medical treatment for angina: the second randomised intervention treatment of angina. Lancet. 350:1997;461-468.
21. Varnauskas E. Twelve-year follow-up of survival in the randomized European Coronary Surgery Study. N Engl J Med. 319:1988;332-337.
22. Alderman E.L., Bourassa M.G., Cohen L.S.et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 82:1990;1629-1646.
23. Madsen J.K., Grande P., Saunamaki K.et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation. 96:1997;748-755.
24. Brorsson B., Lindvall B., Bernstein S.J., Aberg T. CABG in chronic stable angina pectoris patients: indications and outcomes (SECOR/SBU): Swedish Societies for Cardiology, Thoracic Radiology and Thoracic surgery/Swedish Council for Technology Assessment in Health Care. Eur J Cardiothorac Surg. 12:1997;746-752.